imatinib mesylate has been researched along with Arteriosclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, RG; Boucher, P; Gotthardt, M; Herz, J; Li, WP | 1 |
| Allen, TJ; Candido, R; Cao, Z; Cooper, ME; Jandeleit-Dahm, KA; Lassila, M; Thallas, V | 1 |
| Kadowaki, T; Kubota, N | 1 |
| Koskinen, PK; Krebs, R; Lemström, KB; Nykänen, AI; Raisky, O; Sihvola, R; Tikkanen, JM; Wood, J | 1 |
| Aavik, E; Aavik, S; Hayry, P; Lehti, S; Petrov, L; Vamvakopoulos, JE | 1 |
5 other study(ies) available for imatinib mesylate and Arteriosclerosis
| Article | Year |
|---|---|
LRP: role in vascular wall integrity and protection from atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Becaplermin; Benzamides; Cattle; Cell Division; Cell Line; Cholesterol, Dietary; Diet, Atherogenic; Elastin; Enzyme Inhibitors; Imatinib Mesylate; Ligands; Low Density Lipoprotein Receptor-Related Protein-1; Mesenteric Arteries; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction | 2003 |
Imatinib attenuates diabetes-associated atherosclerosis.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Benzamides; Cytokines; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Evaluation, Preclinical; Enzyme Inhibitors; Genes, abl; Genes, sis; Glycated Hemoglobin; Imatinib Mesylate; Intercellular Signaling Peptides and Proteins; Lipids; Male; Mice; Mice, Knockout; Organometallic Compounds; Peptides; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-sis; Pyrimidines; Random Allocation; Receptor, Platelet-Derived Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Systole; Vascular Cell Adhesion Molecule-1 | 2004 |
Protective role of imatinib in atherosclerosis.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Benzamides; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Imatinib Mesylate; Insulin Resistance; Metabolic Syndrome; Mice; Mice, Knockout; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Risk Factors | 2004 |
Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
Topics: Angiogenesis Inhibitors; Animals; Arteriosclerosis; Benzamides; Graft Rejection; Heart Transplantation; Imatinib Mesylate; Inflammation; Male; Muscle, Smooth, Vascular; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Postoperative Complications; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis.
Topics: Angioplasty, Balloon; Animals; Aorta, Abdominal; Arteriosclerosis; Benzamides; Drug Synergism; Hyperplasia; Imatinib Mesylate; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Wistar; Sirolimus | 2006 |